< 1 minute read
Dec. 20, 2021
GS-621763: an Oral Prodrug for SARS-CoV-2
GS-621763
oral antiviral prodrug of remdesivir effective in a ferret SARS-CoV-2 model from remdesivir nucleoside (GS-441524) Nature Communications Gilead Sciences Inc.
oral antiviral prodrug of remdesivir effective in a ferret SARS-CoV-2 model from remdesivir nucleoside (GS-441524) Nature Communications Gilead Sciences Inc.